PAHC Phibro Animal Health Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PAHC

Price (delayed)

$13.61

Market cap

$551.25M

P/E Ratio

36.78

Dividend/share

$0.48

EPS

$0.37

Enterprise value

$993.18M

Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce ...

Highlights
PAHC's P/E is 78% above its 5-year quarterly average of 20.7 and 56% above its last 4 quarters average of 23.6
PAHC's net income has dropped by 59% year-on-year and by 29% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.pahc.com
Peers: ICCC MRK ZTS LLY

Key stats

What are the main financial stats of PAHC
Market
Shares outstanding
40.5M
Market cap
$551.25M
Enterprise value
$993.18M
Valuations
Price to earnings (P/E)
36.78
Price to book (P/B)
2.04
Price to sales (P/S)
0.56
EV/EBIT
21.72
EV/EBITDA
12.33
EV/Sales
1.01
Earnings
Revenue
$982.01M
EBIT
$45.72M
EBITDA
$80.57M
Free cash flow
$37.02M
Per share
EPS
$0.37
Free cash flow per share
$0.91
Book value per share
$6.69
Revenue per share
$24.24
TBVPS
$21.41
Balance sheet
Total assets
$972.71M
Total liabilities
$701.91M
Debt
$474.9M
Equity
$270.8M
Working capital
$398.85M
Liquidity
Debt to equity
1.75
Current ratio
3.12
Quick ratio
1.3
Net debt/EBITDA
5.49
Margins
EBITDA margin
8.2%
Gross margin
30.4%
Net margin
1.5%
Operating margin
5.8%
Efficiency
Return on assets
1.5%
Return on equity
5.4%
Return on invested capital
4.1%
Return on capital employed
5.8%
Return on sales
4.7%
Dividend
Dividend yield
3.53%
DPS
$0.48
Payout ratio
129.7%

PAHC stock price

How has the Phibro Animal Health stock price performed over time
Intraday
4.29%
1 week
4.77%
1 month
12.57%
1 year
-14.35%
YTD
17.53%
QTD
5.26%

Financial performance

How have Phibro Animal Health's revenue and profit performed over time
Revenue
$982.01M
Gross profit
$298.55M
Operating income
$57.29M
Net income
$14.8M
Gross margin
30.4%
Net margin
1.5%
PAHC's net income has dropped by 59% year-on-year and by 29% since the previous quarter
PAHC's net margin has shrunk by 59% YoY and by 29% QoQ
The operating margin has declined by 22% year-on-year
PAHC's operating income is down by 20% year-on-year

Growth

What is Phibro Animal Health's growth rate over time

Valuation

What is Phibro Animal Health stock price valuation
P/E
36.78
P/B
2.04
P/S
0.56
EV/EBIT
21.72
EV/EBITDA
12.33
EV/Sales
1.01
PAHC's P/E is 78% above its 5-year quarterly average of 20.7 and 56% above its last 4 quarters average of 23.6
PAHC's EPS has dropped by 59% year-on-year and by 29% since the previous quarter
PAHC's P/B is 42% below its 5-year quarterly average of 3.5 but 2% above its last 4 quarters average of 2.0
The stock's price to sales (P/S) is 38% less than its 5-year quarterly average of 0.9 and 7% less than its last 4 quarters average of 0.6

Efficiency

How efficient is Phibro Animal Health business performance
Phibro Animal Health's ROA has plunged by 62% YoY and by 29% from the previous quarter
The return on equity has dropped by 61% year-on-year and by 29% since the previous quarter
The ROIC has decreased by 40% YoY and by 15% from the previous quarter
PAHC's return on sales is down by 35% year-on-year and by 15% since the previous quarter

Dividends

What is PAHC's dividend history
Dividend details
DPS
$0.48
Dividend yield
3.53%
Payout ratio
129.7%
Recent dividends

Financial health

How did Phibro Animal Health financials performed over time
Phibro Animal Health's total assets is 39% higher than its total liabilities
Phibro Animal Health's current ratio has decreased by 10% YoY and by 8% QoQ
The quick ratio has decreased by 6% from the previous quarter and by 5% YoY
PAHC's debt is 75% higher than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.